ARCHIVES

Funding Opportunities Listed.

This article is from The Cancer Letter archive.

Vol. 31 No. 02 | January 14, 2005

Download PDF Visit The Full Archive

Related Articles

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

In Brief: Schmidt Of Germany UICC President Elect David Korn Appointed New Dean At Stanford

October 19, 1984

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

Swiss Report On Radiotherapy Mortality Questioned

January 7, 1977

New CREG Cell Kinetics Study Axed By DCTBSC

March 31, 1978